Why is Par Drugs & Che. falling/rising?

As of 22-Sep, Par Drugs & Chemicals Ltd is experiencing a slight decline in its stock price, currently at 112.42, reflecting a decrease of 0.25 or 0.22%. The stock has shown a strong performance over the past week and month, with returns of 6.29% and 13.87%, respectively, outperforming the Sensex, which returned 0.53% and 1.34% in the same periods. However, despite these short-term gains, the stock has significantly underperformed over the year, with a staggering decline of 53.87%. The company has a low debt-to-equity ratio and an attractive return on equity of 14.3, but it has also reported negative results for the last three consecutive quarters, contributing to its poor long-term growth outlook.
In the broader market context, while the stock has outperformed the sector today, it has still underperformed the market over the past year, where the BSE500 index recorded a negative return of 3.80%. The company's recent performance is concerning, as its profits have fallen by 20.32% over the last six months, and non-operating income constitutes a significant portion of its profit before tax. This combination of short-term gains against a backdrop of long-term challenges and negative quarterly results suggests that the stock's recent price movement may not be sustainable, leading to cautious sentiment among investors.